Cargando…

Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy

Bortezomib, a first-generation proteasome inhibitor widely used in chemotherapy for hematologic malignancy, has effective anti-cancer activity but often causes severe peripheral neuropathy. Although bortezomib-induced peripheral neuropathy (BIPN) is a dose-limiting toxicity, there are no recommended...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto, Shota, Egashira, Nobuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830235/ https://www.ncbi.nlm.nih.gov/pubmed/33477371 http://dx.doi.org/10.3390/ijms22020888

Ejemplares similares

Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy
por: Egashira, Nobuaki
Publicado: (2021)

Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy
por: Yamamoto, Shota, et al.
Publicado: (2021)

The protective effects of lafutidine for bortezomib induced peripheral neuropathy
por: Tsukaguchi, Machiko, et al.
Publicado: (2013)

Acupuncture for Bortezomib-Induced Peripheral Neuropathy: Not Just for Pain
por: Zhi, W. Iris, et al.
Publicado: (2018)

Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
por: Kawashiri, Takehiro, et al.
Publicado: (2021)

Immune modulation therapy in the management of bortezomib-induced peripheral neuropathy
por: Jeter, Ashley, et al.
Publicado: (2012)

Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
por: Kawashiri, Takehiro, et al.
Publicado: (2021)

Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy
por: Pero, Maria Elena, et al.
Publicado: (2021)

Acupuncture Treatment for Bortezomib-Induced Peripheral Neuropathy: A Case Report
por: Bao, Ting, et al.
Publicado: (2011)

Bortezomib induced peripheral neuropathy and single nucleotide polymorphisms in PKNOX1
por: Zhou, Xiang, et al.
Publicado: (2023)

Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development
por: Łuczkowska, Karolina, et al.
Publicado: (2022)

Bortezomib-induced aerobic glycolysis contributes to chemotherapy-induced painful peripheral neuropathy
por: Ludman, Taylor, et al.
Publicado: (2019)

Oral administration of Cystine and Theanine ameliorates oxaliplatin-induced chronic peripheral neuropathy in rodents
por: Kawashiri, Takehiro, et al.
Publicado: (2020)

Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats
por: Fujita, Shunsuke, et al.
Publicado: (2015)

Bortezomib-induced painful neuropathy in patients with multiple myeloma
por: Bilińska, Małgorzata, et al.
Publicado: (2013)

Specific Attenuation of Purinergic Signaling during Bortezomib-Induced Peripheral Neuropathy In Vitro
por: Holzer, Anna-Katharina, et al.
Publicado: (2022)

Bortezomib/lenalidomide: Interstitial pneumonitis and peripheral neuropathy: case report
Publicado: (2020)

Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro
por: Shigematsu, Nao, et al.
Publicado: (2020)

Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study
por: Garcia, M Kay, et al.
Publicado: (2014)

Bortezomib-Induced Painful Peripheral Neuropathy: An Electrophysiological, Behavioral, Morphological and Mechanistic Study in the Mouse
por: Carozzi, Valentina A., et al.
Publicado: (2013)

Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
por: Zajączkowska, Renata, et al.
Publicado: (2019)

Clinical, electrophysiological, and cutaneous innervation changes in patients with bortezomib-induced peripheral neuropathy reveal insight into mechanisms of neuropathic pain
por: Bechakra, Malik, et al.
Publicado: (2018)

PB2076: GUIZHI FULING CAPSULE REGULATES AUTOPHAGY TO INTERFERE WITH BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY
por: Fu, Jiaqi, et al.
Publicado: (2023)

Schwann cell autophagy induced by SAHA, 17-AAG, or clonazepam can reduce bortezomib-induced peripheral neuropathy
por: Watanabe, T, et al.
Publicado: (2010)

Omeprazole Suppresses Oxaliplatin-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database
por: Mine, Keisuke, et al.
Publicado: (2022)

Characterization of a rat model of bortezomib‐induced painful neuropathy
por: Duggett, Natalie A, et al.
Publicado: (2017)

Inhibitory Effect of α1 Receptor Antagonists on Paclitaxel-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database
por: Mori, Kohei, et al.
Publicado: (2022)

The Positive Effects of One-Hour Intravenous Administration of Bortezomib on Peripheral Neuropathy in Multiple Myeloma Patients
por: Jung, Joo Young, et al.
Publicado: (2014)

Bortezomib and metformin opposingly regulate the expression of hypoxia-inducible factor alpha and the consequent development of chemotherapy-induced painful peripheral neuropathy
por: Ludman, Taylor, et al.
Publicado: (2019)

Chemotherapy-induced peripheral neuropathy
por: Zhang, Xia, et al.
Publicado: (2017)

Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy
por: Moschetti, Giorgia, et al.
Publicado: (2019)

Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats
por: Mansooralavi, Niloufar, et al.
Publicado: (2023)

Phytohemagglutinin-induced IL2 mRNA in whole blood can predict bortezomib-induced peripheral neuropathy for multiple myeloma patients
por: Watanabe, T, et al.
Publicado: (2013)

Mechanisms, Mediators, and Moderators of the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy
por: Chung, Kaitlin H., et al.
Publicado: (2022)

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
por: Klein, Ines, et al.
Publicado: (2021)

Management of oxaliplatin-induced peripheral neuropathy
por: Saif, M Wasif, et al.
Publicado: (2005)

Inhibition of Ca(2+)/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in Rats
por: Shirahama, Masafumi, et al.
Publicado: (2012)

Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy
por: Minarik, Jiri, et al.
Publicado: (2015)

The resistance mechanisms of proteasome inhibitor bortezomib
por: Lü, Shuqing, et al.
Publicado: (2013)

Platinum accumulation in oxaliplatin‐induced peripheral neuropathy
por: Wei, Guoli, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7h24bvgenqdald14llm8duqehc